(Q39264420)

English

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Nathalie Vergnolle

object named as

N Vergnolle

4

0 references

author name string

C N Andrews

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

T A Griffiths

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

J Kaufman

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M G Surette

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

K P Rioux

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

14 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

374-383

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Dysbiosis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Intestinal microecology and quality of life in irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Role for protease activity in visceral pain in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Clinical relevance of proteinase activated receptors (pars) in the gut

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Drug insight: aminosalicylates for the treatment of IBD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Diversity of the human intestinal microbial flora

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Statistical methods for characterizing diversity of microbial communities by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Irritable bowel syndrome--the new inflammatory bowel disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Mesalamine delivery systems: do they really make much difference?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04732.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04732.X

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39264420&oldid=1817311815"